LGALS3 and thyroiditis: Galectin 3 (Gal-3), which is highly over-expressed in aggressive PTC but undetectable in normal and benign thyroid conditions, is already clinically adopted as an important diagnostic biomarker to distinguish thyroid malignancy from benign nodules.